Compare AbCellera Biologics Inc (ABCL) vs Coinbase Global, Inc. (COIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Coinbase Global, Inc. — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Coinbase Global, Inc. trades at $150.17 (market cap $39.20B). The key difference: Coinbase Global, Inc. is far larger — about 13.1× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Coinbase Global, Inc. nearer its low. Which is the better fit depends on your goals.
| ABCL | COIN | |
|---|---|---|
Market Cap | $2.99B | $39.20B |
Sector | Health | Technology |
52-Week High | $9.76 | $387.27 |
52-Week Low | $2.78 | $141.09 |
Enterprise Value | $2.58B | $36.85B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Coinbase Global, Inc.
Coinbase Global, Inc. is a regulated cryptocurrency company that provides customers around the world with a platform for buying, selling, transferring, and storing digital assets. The Company offers a variety of products and services that enable individuals, businesses, and developers to participate in the cryptoeconomy.
Read more on COIN →
